其 他 安 全 警 示
|
| |
| Australia: Safety Alert: Modafinil: Why 'smart drugs' are not the brightest option (English only) |
| |
The Therapeutic Goods Administration (TGA) is warning consumers that off-label use of “modafinil”, the so-called smart drugs is not a wise choice.
Modafinil has been marketed online as a 'smart drug' that keeps you alert and focused for long periods of time with little to no side effects. Overseas online vendors promote drugs such as Modafinil, one of a growing category of drugs labelled nootropics, by using professional-looking and consumer friendly websites. While Modafinil is available in Australia, online vendors are brushing over the fact that these types of products are illegal to buy and import to Australia without a prescription.
Consumers are advised that when buying medicines online without the right health advice you are potentially putting your health at risk, could lose money in the purchase, and also break the law. Modafinil is listed in Australia as a Schedule 4 prescription-only medicine, which means patients should only access this medicine under the instruction of a medical practitioner. While the above medicine is predominantly prescribed to those living with narcolepsy or sleep apnea, some reports say drugs like Modafinil are becoming popular among students, shift-workers and people working in high-stress jobs. Others are reported to take it for its properties to "modestly increase memory and learning" functions and also as a "cognitive enhancer". As a first step, patients should always seek the advice of your preferred health professional about how to treat poor sleeping habits or ways to properly focus.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/community-qa/modafinil-why-smart-drugs-are-not-brightest-option
In Hong Kong, there is no registered pharmaceutical product containing modafinil. Related news was previously issued by the Medicines and Healthcare products Regulatory Agency (MHRA), and was posted on the Drug Office website on 27 Sep 2016. Members of the public are advised not to purchase pharmaceutical product from sources that are doubtful, including from Internet sites with unknown origin or seller with unknown address, as the product’s safety, quality and efficacy cannot be guaranteed.
Ends/ Wednesday, December 23, 2020
Issued at HKT 17:00
|
| |
|
